{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T06:10:09Z","timestamp":1763619009722},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T00:00:00Z","timestamp":1551139200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ijidonline.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.ijid.2019.02.037","type":"journal-article","created":{"date-parts":[[2019,2,27]],"date-time":"2019-02-27T17:27:57Z","timestamp":1551288477000},"page":"S13-S16","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"S","title":["Exposed! Management of MDR-TB household contacts in an evidence light era"],"prefix":"10.1016","volume":"80","author":[{"given":"Katherine M.","family":"Gaskell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rhiannon","family":"Allen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.J.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2019.02.037_bib0005","series-title":"The V-QUIN MDR TRIAL: a randomized controlled trial of six months of daily levofloxacin for the prevention of tuberculosis among household contacts of patients with multi-drug resistant tuberculosis","author":"ANZCT Registry \u2013 Identifier ACTRN12616000215426","year":"2016"},{"issue":"August (8)","key":"10.1016\/j.ijid.2019.02.037_bib0010","doi-asserted-by":"crossref","first-page":"912","DOI":"10.5588\/ijtld.13.0028","article-title":"Treatment for LTBI in contacts of MDR-TB patients, Federated States of Micronesia, 2009\u20132012","volume":"18","author":"Bamrah","year":"2014","journal-title":"Int J Tuberc Lung Dis"},{"issue":"November","key":"10.1016\/j.ijid.2019.02.037_bib0015","first-page":"475764","article-title":"Resistance at no cost: the transmissibility and potential for disease progression of drug-resistant M. tuberculosis","author":"Becerra","year":"2018","journal-title":"bioRxiv"},{"key":"10.1016\/j.ijid.2019.02.037_bib0020","series-title":"Protecting households on exposure to newly diagnosed index multidrug-resistant tuberculosis patients (PHOENIx MDR-TB)","author":"ClinicalTrials.gov Identifier: NCT03568383","year":"2018"},{"key":"10.1016\/j.ijid.2019.02.037_bib0025","unstructured":"Eurepean Centre for Disease Prevention and Control (ECDC). Public health guidance on management of contacts of MDR TB and XDR TB patients, 2012. [cited 2018 Dec 28] Available from: http:ecdc.europa.eu\/en\/publications-data\/public-health-guidance-management-contacts-mdr-tb-and-xdr-tb-patients"},{"key":"10.1016\/j.ijid.2019.02.037_bib0030","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1183\/09031936.00070812","article-title":"Contact investigation for tuberculosis: a systematic review and meta-analysis","volume":"41","author":"Fox","year":"2013","journal-title":"Eur Respir J"},{"issue":"May","key":"10.1016\/j.ijid.2019.02.037_bib0035","article-title":"The effect of early versus late treatment initiation after diagnosis on the outcomes of patients treated for multidrug-resistant tuberculosis: a systematic review","volume":"16","author":"Harris","year":"2016","journal-title":"BMC Infect Dis"},{"issue":"October","key":"10.1016\/j.ijid.2019.02.037_bib0040","article-title":"The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling","volume":"13","author":"Houben","year":"2016","journal-title":"PLoS Med"},{"key":"10.1016\/j.ijid.2019.02.037_bib0045","series-title":"Tuberculosis child multidrug-resistant preventive therapy: TB CHAMP trial","author":"ISRCTN-ISRCTN92634082","year":"2019"},{"issue":"January (1)","key":"10.1016\/j.ijid.2019.02.037_bib0050","article-title":"Adverse events in healthy individuals and MDR-TB contacts treated with anti-tuberculosis drugs potentially effective for preventing development of MDR-TB: a systematic review","volume":"8","author":"Langendam","year":"2013","journal-title":"PLoS One"},{"issue":"March","key":"10.1016\/j.ijid.2019.02.037_bib0055","doi-asserted-by":"crossref","first-page":"289","DOI":"10.5588\/ijtld.12.0797","article-title":"Systematic screening for active tuberculosis: rationale, definitions and key considerations","volume":"17","author":"Lonnroth","year":"2013","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ijid.2019.02.037_bib0060","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/3905890","article-title":"Is chemoprophylaxis for child contacts of drug-resistant TB patients beneficial? A systematic review","author":"Padmapriyadarsini","year":"2018","journal-title":"Tuberc Res Treat"},{"issue":"December (12)","key":"10.1016\/j.ijid.2019.02.037_bib0065","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1093\/cid\/cit655","article-title":"Preventive therapy for child contacts of multidrug-resistant tuberculosis: a prospective cohort study","volume":"57","author":"Seddon","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2019.02.037_bib0070","series-title":"Post-exposure management of multidrug-resistant tuberculosis contacts: evidence-based recommendations. Policy Brief No. 1","author":"Seddon","year":"2015"},{"issue":"February","key":"10.1016\/j.ijid.2019.02.037_bib0075","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/cid\/cit643","article-title":"Yield of contact investigations in households of patients with drug-resistant tuberculosis: systematic review and meta-analysis","volume":"58","author":"Shah","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2019.02.037_bib0080","doi-asserted-by":"crossref","first-page":"288","DOI":"10.5588\/ijtld.11.0437","article-title":"Lack of evidence to support policy development for management of contacts of multidrug-resistant tuberculosis patients: two systematic reviews","volume":"16","author":"van der Werf","year":"2012","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ijid.2019.02.037_bib0085","series-title":"Global tuberculosis report","author":"WHO","year":"2018"},{"key":"10.1016\/j.ijid.2019.02.037_bib0090","series-title":"Rapid communication: key changes to treatment of multidrug- and rifampicin-resistant tuberculosis (MDR\/RR-TB)","author":"WHO","year":"2019"},{"key":"10.1016\/j.ijid.2019.02.037_bib0095","series-title":"Updated and consolidated guidelines for programmatic management","article-title":"Latent TB Infection","author":"WHO","year":"2019"},{"key":"10.1016\/j.ijid.2019.02.037_bib0100","series-title":"GRADE profile tables for new recommendations","article-title":"Latent tuberculosis infection: updated and consolidated guidelines for programmatic management: annex 1","author":"World Health Organization","year":"2018"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971219301018?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971219301018?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,8]],"date-time":"2019-03-08T22:13:15Z","timestamp":1552083195000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971219301018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":20,"alternative-id":["S1201971219301018"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2019.02.037","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exposed! Management of MDR-TB household contacts in an evidence light era","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2019.02.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}